Literature DB >> 7997248

Retinoblastoma protein regulation of surface CD74 (invariant chain) expression in breast carcinoma cells.

Y Lu1, G D Ussery, M Jacim, M Tschickardt, J M Boss, G Blanck.   

Abstract

The HLA class II genes encode heterodimeric cell surface proteins which bind peptide antigen recognized by T-cell receptors on CD4+ T-cells. The class II proteins are inducible by IFN-gamma, and this induction requires, or is strongly enhanced, by retinoblastoma protein (RB) in a series of breast carcinoma cell lines. Loading of peptide onto the class II protein appears to be regulated by CD74, which associates with class II during their transition to the endosomal compartment, where class II binds peptide. Class II proteins and CD74 are largely regulated in concert, provoking the question, is CD74 induction by IFN-gamma affected by RB? Results described here indicate that IFN-gamma induction of CD74 surface expression in a series of breast carcinoma lines is enhanced by RB, while RB has no effect on CD74 mRNA induction. Also, neither the class II nor the CD74 promoter regions are activated by RB in cotransfection experiments where RB activates the SV40 promoter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7997248     DOI: 10.1016/0161-5890(94)90055-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  3 in total

1.  Retinoblastoma protein expression facilitates chromatin remodeling at the HLA-DRA promoter.

Authors:  A Osborne; M Tschickardt; G Blanck
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

Review 2.  The RB tumor suppressor at the intersection of proliferation and immunity: relevance to disease immune evasion and immunotherapy.

Authors:  Jack Hutcheson; Agnieszka K Witkiewicz; Erik S Knudsen
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Retinoblastoma protein potentiates the innate immune response in hepatocytes: significance for hepatocellular carcinoma.

Authors:  Jack Hutcheson; Ryan J Bourgo; Uthra Balaji; Adam Ertel; Agnieszka K Witkiewicz; Erik S Knudsen
Journal:  Hepatology       Date:  2014-08-28       Impact factor: 17.425

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.